Showing posts with label WHO. Show all posts
Showing posts with label WHO. Show all posts

Sunday, 30 March 2025

A Comprehensive Review of the Most Devastating and Catastrophic Return of Fear and Uncertainty: The Covid-19 Crisis | Chapter 11 | Disease and Health: Research Developments Vol. 7

 In 2019, the world witnessed the beginnings of a global pandemic in the form of a new respiratory illness. Covid-19, also known as coronavirus disease 2019, is a highly contagious infectious disease caused by the novel coronavirus “SARS-CoV-2”. Covid-19 is the news once again making headlines and announcing its comeback. It has had a profound impact since its December 2019 emergence from Wuhan, China. The 2019 outbreak was a turning point affecting nearly every country with varying degrees of devastating and catastrophic severity. It has led to significant worldwide mortality and morbidity causing millions of deaths and long-lasting health complications for many, directly or indirectly. The rapid spread worldwide, led to the World Health Organization calling it a “global pandemic” on March 11, 2020. It has reshaped the world’s healthcare systems, caused economic disruptions and forced significant changes in lifestyle. Since the beginning of the Covid-19 pandemic up until the end of 2024, there have been over 800 million globally confirmed cases. During the same period, the world-wide death rate was just over 7 million with 13 billion Covid-19 vaccinations administered globally. The scar left by Covid-19 is witnessed on the face of every individual and every sector of the economy. Anytime a viral outbreak has the potential to take hold, a containment strategy must be followed in order to keep it from becoming a pandemic. This study is a detailed presentation of the covid crisis. Covid-19 is a viral zoonotic disease which spreads from animals-to-humans and humans-to-humans. It is caused by the novel SARS-CoV-2 coronavirus. Covid-19 is an enveloped, positive-sense single-stranded RNA virus that attaches to the host cell through its spike protein which facilitates entry into the host cell via the ACE2 receptors. The virus primarily spreads through respiratory droplets of an infected person when coughing, sneezing or talking and can also spread via contact with contaminated surfaces. Asymptomatic or pre-symptomatic individuals can also spread the disease. Covid-19 has caused major social, economic, business and lifestyle disruptions. Covid-19 symptoms range from mild to severe and appear between 2-14 days after exposure. The most common symptoms include fever, cough, shortness of breath, fatigue, muscle or body aches, loss of taste or smell, headache, nausea or vomiting and diarrhea. In more severe cases, it can cause pneumonia, ARDS, organ failure and even death. A Covid-19 diagnosis is mainly done by polymerase chain reaction (PCR) - the gold standard of testing. Histologically, Covid-19 is responsible for many changes to the lungs, heart, kidneys, liver and GI tract. Symptoms lasting beyond the primary infection (“long-covid”) have shown to have a significant impact on an individual’s daily life. There are several factors that increase the risk of infection. Individuals who are over 60 versus younger individuals, individuals with comorbidities, those who are immunocompromised, those who smoke, use alcohol, lack exercise or are unvaccinated, all have a higher risk of infection. Infected individuals with underlying health conditions can experience a host of complications such as mild to severe organ impairment (heart, liver, kidney, brain), diabetes, dementia, neurological issues, GI issues, and hematological or muscular pain. The risk also increases for individuals who are lower on the socio-economic spectrum. One of the most prominent features of the Covid virus is its ability to mutate over time. This leads to the emergence of variants with different properties. Currently, there is no definite treatment for Covid-19. The Centers for Disease Control and Prevention (CDC) recommends the use of vaccines, antiviral drugs, immunomodulators, monoclonal antibodies and non-pharmaceutical interventions (wearing masks, social distancing, hand hygiene, quarantine, isolation) to reduce the transmission risk, prevent hospitalization and to avoid severe illness or death. The advent of highly efficacious vaccines using novel mRNA technology has seen the effects of the disease wane. The Covid-19 outbreak brought to light some very stark realities. It is abundantly clear there is no influence over animal biology, their disease reservoirs, the host type (bats, mosquitoes), virus mutation, etc. From a societal standpoint, there is no influence over social behavior (collective, individual), socio-economic disparities, age, gender, comorbidities or national resources. Looking at these factors alone, one can see the insurmountable task of controlling another outbreak. Covid-19 infection rates are slowing and the pandemic is giving way to an endemic. However, one question remains - how well prepared are we for the next major outbreak?

 

Author (s) Details

 

M Waheed Roomi
Rath Research Institute, San Jose, California. USA.

 

Please see the book here:- https://doi.org/10.9734/bpi/dhrd/v7/4582

Tuesday, 16 April 2024

Role of Community Health Officer or Middle Level Health Worker in India | Chapter 9 | Recent Updates in Disease and Health Research Vol. 5

In 2019, India introduced a novel healthcare provider role known as the Community Health Officer (CHO), aimed at bolstering the Health and Wellness Centers at the community level. The CHO, also referred to as the Mid-Level Health Provider (MLHP) or non-physician practitioner, is a trained healthcare professional with a defined scope of practice.

 

In India, eligibility for this position is restricted to Nursing and AYUSH Practitioners. CHO's are equipped with specialized training and authorized to deliver healthcare services in a broader range of scenarios than other healthcare professionals, though their scope remains narrower than that of physicians.

 

The role of the CHO serves to bridge the gap between healthcare facilities and the population seeking medical care. By functioning as a mid-level healthcare provider, CHO's alleviate the burden on other healthcare professionals and contribute to the overarching goal of achieving universal health coverage. This review aims to provide a fresh perspective on the CHO role within the global context.


Author(s) Details:

Nirmali Gogoi,
Faculty of Nursing, Assam Down Town University, India.

Lakhimi Gogoi,
Faculty of Nursing, Assam Down Town University, India.

Please see the link here: https://stm.bookpi.org/RUDHR-V5/article/view/14069

Wednesday, 3 April 2024

Stem Cell Therapy: A Potential Solution for Covid-19 | Chapter 1 | New Visions in Medicine and Medical Science Vol. 3

 Coronavirus (Covid-19) is a contagious and infectious disease that has caused a global pandemic. The World Health Organization (WHO) has declared this a global pandemic as Covid-19 has spread throughout the world causing over 2.9 million deaths. Consequently, companies have manufactured vaccines to combat the spread of Covid-19 and protect those who become vaccinated. However, the current vaccines do not seem to be effective against the new variants of the virus that have emerged. Stem cell therapy could be an alternative. This study aims to find an alternative solution to combat the new variant of Covid-19. Stem cells therapy is a potential noninvasive method for treating the emerging variants of SARS-COV-2 that the coronavirus vaccine is ineffective against. The immunomodulatory effects from stem cell therapy can inhibit the immune system overactivation therefore lower the mortality rate by preventing or attenuating the cytokine storm caused by Covid-19. It can reduce time to recovery with its regenerative effects by repairing damages caused by Covid-19 and improving bodily functions. In addition, unlike most traditional medicine, no adverse effects have been observed after treatment. All this suggests that stem cell therapy is a promising and viable solution to combat and treat Covid-19. This study examined that the Covid-19 can potentially be treated by stem cell therapy as stem cells can greatly improve the symptoms of patients with mild, moderate, and severe coronavirus infections, and repair the damage.


Author(s) Details:

Fu Nan Wang,
American Stem Cell Base, Los Angeles, CA, USA and Stem Cell Life Science Corporation, New Taipei City, Taiwan.

Ming Chu Hsu,
American Stem Cell Base, Los Angeles, CA, USA and Stem Cell Life Science Corporation, New Taipei City, Taiwan.

Sebo Ling Wang,
American Stem Cell Base, Los Angeles, CA, USA.

Sebo Gene Wang,
American Stem Cell Base, Los Angeles, CA, USA.

Wei Chun Chen,
Stem Cell Life Science Corporation, New Taipei City, Taiwan.

Tsung Dao Lee,
Stem Cell Life Science Corporation, New Taipei City, Taiwan.

Sebo Michelle Wang,
Loma Linda University School of Medicine, Loma Linda, CA, USA.

Howard Doong,
LifeCode Biotech Company, Taipei, Taiwan.

Please see the link here: https://stm.bookpi.org/NVMMS-V3/article/view/13948

Thursday, 5 October 2023

Respectful Care as a Human Right: Key Components of Implementing “Respectful Maternity Care” | Chapter 11 | Current Innovations in Disease and Health Research Vol. 7

 Over ancient times few decades the concept of “mannerly maternity care” has developed and expanded to have devotion holistic approach. Respectful parenthood care is a critical but frequently neglected field of quality healthcare. It is not only a important component ofquality of care but it is also ahuman right. World Health Organization approval states that: Respectful maternity care – that refers to care organized for and determined to all women in theory that maintains their nobility, privacy and secrecy, ensures privilege from harm and mistreatment, and enables cognizant choice and continuous support all along labor and childbirth – is urged.Over 90 global institutions, including the International Federation of Gynecology and Obstetrics (FIGO) and the International Confederation of Midwives (ICM), have signed a statement from WHO employment on governments, healthcare institutions and healthcare providers for fear that and eliminate disregard and abuse during ability-based parturition. In this chapter, we review the evidence of courteous maternity care and consider about the significant concerns for professional practice for health care providers.

Author(s) Details:

Nongmeikapam Monika,
Faculty of Nursing, Assam Down Town University, Assam, India.

Nirmali Gogoi,
Faculty of Nursing, Assam Down Town University, Assam, India.

Please see the link here: https://stm.bookpi.org/CIDHR-V7/article/view/12070

Tuesday, 28 March 2023

The Performance of the Health Care System in Yemen before and after the War | Chapter 9 | Recent Progress in Science and Technology Vol. 8

 This paper inquires to assess the conduct of the healthcare system in Yemen pre- and during-conflict 2010-2020 and to try the impact of the conflict on the healthcare system efficiency during the ending 2015-2020. Yemen's prolonged war has ravaged allure energy plan. Fighting, underfunding, and diesel shortages have wreaked havoc on the country with its own government's underdeveloped capacity grid and abandoned communities and cities outside electricity Yemen is an architectural finish one of calamity humanitarian crises in the world on account of the ongoing conflict that has started in 2013. A literature review from 2010 to 2020 of the evidence stated by international and local organizations in addition to in published and classified articles and reports. The study used the Building Blocks foundation developed for one WHO (2007; 2009) (hereafter WHO-BB). According to the findings before the war, Yemen's healthcare scheme was plagued by governance issues and dishonesty, a significant capital gap in the healthcare area, an uneven distribution of healthcare peasants, lax drug regulations, and incompetent health information. Additionally, the belongings of war on the healthcare system were destructive. Yemen's healthcare system is ineffective and loose. The government needs to rearrange the domestic healthcare manufacturing with the assistance of global fitness organisations in order to resolve this question.

Author(s) Details:

Ahlam Esmail Alnaqeb,
Doha Institute for Graduate Studies, School of Economics, Administration and Public Policies, Qatar.

Please see the link here: https://stm.bookpi.org/RPST-V8/article/view/10065

Thursday, 13 October 2022

India's Regulatory Frames for Adoption of Repurposed Drugs as Covid-19 Treatment: A Recent Study Approach | Chapter 3 | Current Innovations in Medicine and Medical Science Vol. 3

 Presently, there are no treatment options available for the fatal contagious complaint, coronavirus complaint 2019( COVID- 19). The COVID- 19 complaint caused by the SARS- CoV- 2 coronavirus is a global public health exigency. The SARS- CoV-2-caused COVID- 19 epidemic represents an unknown health trouble, challenging the quick development of antiviral treatments. Repurposing a drug exemplifies a new strategy for medicine development in order to probe possible remedial benefits in clinical trials. The fashion is applied to overcome the backups of fiscal support, time, and plutocrat in conventional medicine development. Several innovative and data- driven approaches to relating repurposable drug campaigners have been proposed. nonetheless, substantial technological and nonsupervisory obstacles must be surmounted. Several specifics were approved for the treatment of COVID- 19 cases as a result of the repurposed SARS- CoV- 2 treatments. For pharmaceutical businesses to admit a manufacturing licence from the medicine controller, it's pivotal that they cleave to the nonsupervisory rules and procedures. The Indian medicine controller, CDSCO, has specific criteria and procedures for getting a manufacturing licence for every new drug, expression, or vaccination. Clinical trials, expression development, and marketable manufacturing all bear nonsupervisory authorization. After clinical trials and expression development, particular forms and processes should be used to submit data to the Indian nonsupervisory agency. The controller will assess the information and the decision to do to the coming phase. This composition is the product of an total disquisition into the nonsupervisory frame that a pharmaceutical company must cleave to in order to vend repurposed medicinals. general brands have a distinct manufacturing process.


Author(s) Details:

K. S. Deeksha,
Pharmaceutical Regulatory Affairs Group, Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Sri Shivarathreeshwara Nagara, Mysuru – 570015, Karnataka, India.

V. Balamuralidhara,
Pharmaceutical Regulatory Affairs Group, Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Sri Shivarathreeshwara Nagara, Mysuru – 570015, Karnataka, India.

K. R. Gowthami,
Pharmaceutical Regulatory Affairs Group, Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Sri Shivarathreeshwara Nagara, Mysuru – 570015, Karnataka, India.

V. Thoyajaksha,
Pharmaceutical Regulatory Affairs Group, Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Sri Shivarathreeshwara Nagara, Mysuru – 570015, Karnataka, India.

D Thanush,
Pharmaceutical Regulatory Affairs Group, Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Sri Shivarathreeshwara Nagara, Mysuru – 570015, Karnataka, India.

Please see the link here: https://stm.bookpi.org/CIMMS-V3/article/view/8377

Sunday, 27 February 2022

Analysis of COVID-19 Epidemic in Pakistan and the Vaccination Strategies | Chapter 09 | Emerging Trends in Disease and Health Research Vol. 3

 The current COVID-19 pandemic was initially detected in Wuhan, China, in December 2019, and has since spread throughout the world. The World Health Organization (WHO) has proclaimed the coronavirus pandemic to be a global public health emergency. On February 11, 2020, the World Health Organization (WHO) validated the virus's nomenclature as Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). COVID-19 transmission was controlled using a variety of efficient preventive strategies. Following the onset of the COVID-19 pandemic in Pakistan, the government devised a number of efficient strategies to combat the zoonotic illness. In all provinces, the Pakistani government built tertiary care hospitals, quarantine facilities, and COVID-19 testing laboratories. Currently, a large vaccination campaign is underway to immunise as much of the population as possible in order to bring the epidemic under control. The spread of COVID-19, as well as its effects on the Pakistani populace and government responses to manage the epidemic, were highlighted in this review.


Author(S) Details


Arslan Habib
Laboratory of Molecular Immunology, School of Life Sciences, Fudan University, Shanghai, China.

Riffat Iqbal
Department of Zoology, Government College University Lahore, Pakistan.

Zeeshan Ashraf
Department of Fisheries & Aquaculture, University of Veterinary & Animal Sciences, Lahore, Pakistan.

Muhammad Usman Taj
Department of Fisheries & Aquaculture, University of Veterinary & Animal Sciences, Lahore, Pakistan.

Dominic Kwesi Quainoo
Department of Biotechnology, Faculty of Biosciences, University for Development Studies, Ghana.

Muhammad Shehzad
Department of Zoology, Government College University Lahore, Pakistan.

Mubeen Ameer
Department of Zoology, Government College University Lahore, Pakistan.

Behloul Abbas
Department of Zoology, University of Agriculture Faisalabad, Pakistan.

View Book:- https://stm.bookpi.org/ETDHR-V3/article/view/5882

Tuesday, 17 August 2021

Determination of Prescribing Pattern of Drugs in Acute Respiratory Tract Infection in Children at Tertiary Care Teaching Hospital, India | Chapter 13 | New Frontiers in Medicine and Medical Research Vol. 2

 Acute respiratory tract infections (ARTI) are common among people of all ages. Infections of the respiratory system in children cause a lot of morbidity and mortality. It is a major health issue in India as well. Pneumonia kills 2 million children under the age of five, according to the World Health Organization (WHO). The majority of ARTIs are caused by viruses. The principal causative agents include rhinoviruses, respiratory syncytial viruses, parainfluenza and influenza viruses, human metapneumovirus, and adenoviruses. ARTIs are caused by bacteria such as group A streptococci, Corynebacterium diphtheriae, Neisseria meningitides, Haemophilus influenzae, pneumococcus, and Staphylococcus aureus. Drug utilisation studies aid in determining the pattern of prescriptions for distinct illnesses in a given location. Our goal was to investigate medicine prescribing patterns and assess their rationale in children aged 1 to 5 years with acute respiratory tract infection.

We looked at 298 medications that were given to these kids. These prescriptions were analysed, and they were compared to WHO prescription indicators. Cough (96 percent), fever (93 percent), and rhinitis (82.5 percent) were the most prevalent symptoms, but sore throat, earache, and shortness of breath were also seen in these kids. The average number of medicines prescribed per patient was 4.1. Antipyretics were prescribed 98.3% of the time, antimicrobials 91.3 percent of the time, antihistaminics and cough syrups 75.2 percent of the time, Leukotriene antagonists 25.1 percent of the time, Vitamin B complex 11% of the time, and glucocorticoids 4.6 percent of the time. All of the medications were prescribed using brand names rather than generic names. 97.3 percent of the pharmaceuticals prescribed came from the national list of essential medications. In our research, we discovered an over use of antimicrobials. Antimicrobials must be used responsibly, which necessitates educational programmes. At the same time, parents should be made aware of the dangers of antibiotic use.

Author (S) Details

Sujata Jadhav
Department of Pharmacology, Krishna Institute of Medical Sciences, Karad, Maharashtra, India.

Chitra Khanwelkar
Department of Pharmacology, Krishna Institute of Medical Sciences, Karad, Maharashtra, India.

Abhay Jadhav
Department of Pharmacology, Krishna Institute of Medical Sciences, Karad, Maharashtra, India.

View Book :- https://stm.bookpi.org/NFMMR-V2/article/view/2686

Friday, 5 June 2020

Study on Physico–chemical Properties and Some Heavy Metal Contents in Public Water Sources in Tuzla and Its Surrounding, Bosnian and Herzegovina | Chapter 10 | Recent Advances in Science and Technology Research Vol. 1

This paper presents the results of physico-chemical parameters and heavy metals (Cu, Zn, Pb and Cd) contents in water sources of public supply of Tuzla and the surrounding area, as alternative sources of water supply. The study area was divided into six (6) sampling sites and their respective position was detected using GPS device (MAGELLAN EXPLORIST 210). The heavy metals were determined using Atomic Absorption Spectrophotometry (AAS), While, the physico-chemical parameters (pH, electrical conductivity (EC), carbonate, total hardness, nitrate (NO3 -N), nitrite (NO2 N), ammonia (NH3 -N), KMnO4 and chlorides were determined using standard methods. The heavy metal contents: Cu (1-6 μg/L) and Zn (1-2 μg/L). Pb was only detected Simin Han well water at 2 μg/L. Cd was below detection limits in all samples. The levels of Zn, Cu, Cd and Pb in Tuzla and its surrounding alternative drinking sources are within the permissible limits according to the Regulations on the safety of drinking water of Bosnia and Herzegovina and WHO. The physico–chemical properties of the water samples from the study area are within the recommended level of exposure, except for ammonia in the well of Miladije 2 and pH of Miladije 1. Concentrations of the investigated parameters in samples of drinking water alternative sources of public supply of Tuzla and its surrounding area within the allowed limits according to World.

Author(s) Details

Almir Šestan
Department of Chemistry, Faculty of Natural Sciences and Mathematics, University of Tuzla, Bosnia and Herzegovina.

Aida Crnkić
Department of Chemistry, Faculty of Natural Sciences and Mathematics, University of Tuzla, Bosnia and Herzegovina.

Aldina Kesić
Department of Chemistry, Faculty of Natural Sciences and Mathematics, University of Tuzla, Bosnia and Herzegovina.

Zorica Hodžić
Department of Chemistry, Faculty of Natural Sciences and Mathematics, University of Tuzla, Bosnia and Herzegovina

Indira Šestan
Department of Physical Chemistry and Electrochemistry, Faculty of Technology, University of Tuzla, Bosnia and Herzegovina.

View Book: - http://bp.bookpi.org/index.php/bpi/catalog/book/175